Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Oncologist ; 28(6): e341-e349, 2023 06 02.
Artículo en Inglés | MEDLINE | ID: mdl-37027521

RESUMEN

BACKGROUND: Severe chemotherapy-related toxicities are frequent among older patients. The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) and the Cancer and Aging Research Group Study (CARG) score were both developed to predict these events. PATIENTS AND METHODS: The objective of this study was to evaluate the scores' predictive performance in a prospective cohort, which included patients aged 70 years and older referred for a geriatric assessment prior to chemotherapy for a solid tumor. The main endpoints were grades 3/4/5 toxicities for the CARG score and grades 4/5 hematologic toxicities and grades 3/4/5 non-hematologic toxicities for the CRASH score. RESULTS: A total of 248 patients were included, of which 150 (61%) and 126 (51%) experienced at least one severe adverse event as defined respectively in CARG and CRASH studies. The incidence of adverse events was not significantly greater in the intermediate and high-risk CARG groups than in the low-risk group (odds ratio (OR) [95% CI] = 0.3 [0.1-1.4] (P = .1) and 0.4 [0.1-1.7], respectively). The area under curve (AUC) was 0.55. Similarly, the incidence of severe toxicities was no greater in the intermediate-low, intermediate-high, and high-risk CRASH groups than in the low-risk CRASH group (OR [95%CI] = 1 [0.3-3.6], 1 [0.3-3.4], and 1.5 [0.3-8.1], respectively). The AUC was 0.52. The type of cancer, performance status, comorbidities, body mass index, and MAX2 index were independently associated with grades 3/4/5 toxicities. CONCLUSION: In an external cohort of older patients referred for a pretherapeutic GA, the CARG and CRASH scores were poor predictors of the risk of chemotherapy severe toxicities.


Asunto(s)
Antineoplásicos , Neoplasias , Anciano , Humanos , Anciano de 80 o más Años , Antineoplásicos/efectos adversos , Estudios Prospectivos , Neoplasias/tratamiento farmacológico , Neoplasias/epidemiología , Evaluación Geriátrica , Factores de Riesgo
2.
J Neurosci ; 34(18): 6389-404, 2014 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-24790209

RESUMEN

A remarkable feature of early neuronal networks is their endogenous ability to generate spontaneous rhythmic electrical activity independently of any external stimuli. In the mouse embryonic SC, this activity starts at an embryonic age of ∼ 12 d and is characterized by bursts of action potentials recurring every 2-3 min. Although these bursts have been extensively studied using extracellular recordings and are known to play an important role in motoneuron (MN) maturation, the mechanisms driving MN activity at the onset of synaptogenesis are still poorly understood. Because only cholinergic antagonists are known to abolish early spontaneous activity, it has long been assumed that spinal cord (SC) activity relies on a core network of MNs synchronized via direct cholinergic collaterals. Using a combination of whole-cell patch-clamp recordings and extracellular recordings in E12.5 isolated mouse SC preparations, we found that spontaneous MN activity is driven by recurrent giant depolarizing potentials. Our analysis reveals that these giant depolarizing potentials are mediated by the activation of GABA, glutamate, and glycine receptors. We did not detect direct nAChR activation evoked by ACh application on MNs, indicating that cholinergic inputs between MNs are not functional at this age. However, we obtained evidence that the cholinergic dependency of early SC activity reflects a presynaptic facilitation of GABA and glutamate synaptic release via nicotinic AChRs. Our study demonstrates that, even in its earliest form, the activity of spinal MNs relies on a refined poly-synaptic network and involves a tight presynaptic cholinergic regulation of both GABAergic and glutamatergic inputs.


Asunto(s)
Acetilcolina/metabolismo , Potenciales de Acción/fisiología , Uniones Comunicantes/fisiología , Ácido Glutámico/metabolismo , Glicina/metabolismo , Neuronas Motoras/fisiología , Red Nerviosa/fisiología , Médula Espinal/citología , Ácido gamma-Aminobutírico/metabolismo , Acetilcolina/farmacología , Potenciales de Acción/efectos de los fármacos , Animales , Colinérgicos/farmacología , Embrión de Mamíferos , Fármacos actuantes sobre Aminoácidos Excitadores/farmacología , Femenino , Uniones Comunicantes/efectos de los fármacos , Uniones Comunicantes/metabolismo , Ácido Glutámico/farmacología , Glicina/farmacología , Proteínas de Homeodominio/genética , Técnicas In Vitro , Ratones , Ratones Transgénicos , Neuronas Motoras/efectos de los fármacos , Red Nerviosa/efectos de los fármacos , Embarazo , Tetrodotoxina/farmacología , Factores de Transcripción/genética , Ácido gamma-Aminobutírico/farmacología
3.
J Neurosci ; 30(1): 390-403, 2010 Jan 06.
Artículo en Inglés | MEDLINE | ID: mdl-20053920

RESUMEN

Rhythmic electrical activity is a hallmark of the developing embryonic CNS and is required for proper development in addition to genetic programs. Neurotransmitter release contributes to the genesis of this activity. In the mouse spinal cord, this rhythmic activity occurs after embryonic day 11.5 (E11.5) as waves spreading along the entire cord. At E12.5, blocking glycine receptors alters the propagation of the rhythmic activity, but the cellular source of the glycine receptor agonist, the release mechanisms, and its function remain obscure. At this early stage, the presence of synaptic activity even remains unexplored. Using isolated embryonic spinal cord preparations and whole-cell patch-clamp recordings of identified motoneurons, we find that the first synaptic activity develops at E12.5 and is mainly GABAergic. Using a multiple approach including direct measurement of neurotransmitter release (i.e., outside-out sniffer technique), we also show that, between E12.5 and E14.5, the main source of glycine in the embryonic spinal cord is radial cell progenitors, also known to be involved in neuronal migration. We then demonstrate that radial cells can release glycine during synaptogenesis. This spontaneous non-neuronal glycine release can also be evoked by mechanical stimuli and occurs through volume-sensitive chloride channels. Finally, we find that basal glycine release upregulates the propagating spontaneous rhythmic activity by depolarizing immature neurons and by increasing membrane potential fluctuations. Our data raise the question of a new role of radial cells as secretory cells involved in the modulation of the spontaneous electrical activity of embryonic neuronal networks.


Asunto(s)
Glicina/metabolismo , Periodicidad , Médula Espinal/embriología , Médula Espinal/metabolismo , Potenciales Sinápticos/fisiología , Animales , Células CHO , Células Cultivadas , Cricetinae , Cricetulus , Femenino , Ratones , Neuronas Motoras/citología , Neuronas Motoras/metabolismo , Embarazo , Médula Espinal/citología
4.
Eur J Neurosci ; 27(10): 2529-41, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18445051

RESUMEN

In the hypoglossal nucleus of wild-type mice, early mixed glycinergic-GABAergic inhibitory transmission becomes mainly glycinergic during postnatal maturation. In spastic mice (SPA), a model of human hyperekplexic syndrome, an insertion into the gene of the glycine receptor (GlyR) beta subunit results in a decreased accumulation of GlyRs at postsynaptic sites and an impaired glycinergic neurotransmission. In SPA mice displaying a mild phenotype (B6C3Fe strain), a compensatory process involving an increased aggregation of GABA(A) receptors (GABA(A)Rs) at postsynaptic sites was proposed to explain survival of mutant animals until adulthood. However, C57BL/6J strain SPA mice which express a lower amount of GlyR beta subunit die 2-3 weeks after birth, suggesting that GABAergic compensation does not necessarily take place. We performed a morphofunctional study of inhibitory synapses in the developing hypoglossal nucleus of C57BL/6J SPA mice. In this mutant, the inhibitory synaptic activity was mainly GABAergic. Accordingly, we observed a developmental loss of glycinergic presynaptic terminals and an increase in the density of GABAergic presynaptic terminals during the first two postnatal weeks. In addition, while C57BL/6J SPA mice displayed a strong impairment in GlyR aggregation at postsynaptic loci, the proportion of inhibitory presynaptic terminals facing diffuse GABA(A)Rs significantly increased during development. Our results suggest crosstalk between postsynaptic and presynaptic elements, leading to the developmental regulation of the presynaptic terminal neurotransmitter content according to the level of postsynaptic GlyR aggregation. They also indicate that GABAergic neurotransmission does not compensate for defects in GlyR postsynaptic aggregation leading to spastic syndrome in C57BL/6J SPA mice.


Asunto(s)
Nervio Hipogloso/metabolismo , Neuronas Motoras/metabolismo , Inhibición Neural/genética , Receptores de Glicina/metabolismo , Sinapsis/metabolismo , Ácido gamma-Aminobutírico/metabolismo , Envejecimiento/fisiología , Animales , Diferenciación Celular/genética , Nervio Hipogloso/citología , Nervio Hipogloso/crecimiento & desarrollo , Bulbo Raquídeo/citología , Bulbo Raquídeo/crecimiento & desarrollo , Bulbo Raquídeo/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes Neurológicos , Neuronas Motoras/efectos de los fármacos , Espasticidad Muscular/genética , Espasticidad Muscular/metabolismo , Espasticidad Muscular/fisiopatología , Inhibición Neural/efectos de los fármacos , Terminales Presinápticos/efectos de los fármacos , Terminales Presinápticos/metabolismo , Agregación de Receptores/efectos de los fármacos , Agregación de Receptores/genética , Receptor Cross-Talk/fisiología , Receptores de GABA-A/efectos de los fármacos , Receptores de GABA-A/metabolismo , Receptores de Glicina/efectos de los fármacos , Receptores de Glicina/genética , Sinapsis/efectos de los fármacos , Membranas Sinápticas/efectos de los fármacos , Membranas Sinápticas/metabolismo , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...